is berberine a glp 1 agonist as Bioactive Alkaloid: Multi-Omics Perspectives on Its Role in Obesity Management Figure 2, Health Canada collection_metabolism Skin Boost Plus (Flavor):Acai Lemonade

is berberine a glp 1 agonist as Bioactive Alkaloid: Multi-Omics Perspectives on Its Role in Obesity Management Figure 2, Health Canada collection_metabolism Skin Boost Plus (Flavor):Acai Lemonade

Figure 2, Health Canada Approval Timeline for GLP-1 Receptor Agonists by Marketed Date and NOC Dates - Formulary Management of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists - NCBI Bookshelf

According to FDA prescribing information, these include: Nausea (occurring in 15–44% of patients depending on the specific agent and dose) Vomiting (5–24% of patients) Diarrhea (8–21% of patients) Constipation (10–24% of patients) Abdominal pain or discomfort (5–14% of patients) These symptoms typically emerge during dose initiation or escalation and often diminish over several weeks as the body adapts

collection_metabolism

Skin Boost Plus (Flavor):Acai Lemonade

However, with the shortage resolved, the FDA expects these compounded versions to be phased out, as they are not FDA-approved and may pose safety risks